The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients

Mhd Y. Al-Marrawi, Brian I. Rini, Lauren C. Harshman, Georg Bjarnason, Lori Wood, Ulka Vaishampayan, Mary MacKenzie, Jennifer J. Knox, Neeraj Agarwal, Hulayel Al-Harbi, Christian Kollmannsberger, Min Han Tan, Sun Young Rha, Frede N. Donskov, Scott North, Toni K. Choueiri, Daniel Y. Heng